- Services & Solutions
- By Business Need
- Infrastructure Transformation Services
- Cloud Computing
- Business Process Management
- Business Technology
- Transforming the IT Function
- Cost Optimization
- Risk Management & Compliance
- Corporate Responsibility and Sustainability
- Merger & Acquisition
- Global Sourcing and Industrialization
- Finance Transformation
- Supply Chain Management
- Human Capital Management
- Customer Interaction
- By Industry
- Consulting Services
- Outsourcing Services
- Technology Services
- Local Professional Services
- Application Services
- BUSINESS PROCESS OUTSOURCING
- BUSINESS INFORMATION MANAGEMENT
- BUSINESS PROCESS MANAGEMENT
- MOBILE SOLUTIONS
- SMART ENERGY SERVICES
- TESTING SERVICES
- By Business Need
- Insights & Resources
- News & Events
- About Us
Life Sciences
Vision & Reality
Vision & Reality provides a unique perspective on the most pressing life sciences industry challenges, and offers strategies and methods to overcome them. In our latest research, we focus on the issues surrounding patient adherence.
Patient Adherence: The Next Frontier in Patient Care - Key findings from Capgemini’s latest Vision & Reality research
Lack of patient adherence to prescribed medications poses a tremendous challenge to the global healthcare community. Bridging the adherence gap is a ‘must do’ for pharmaceutical companies to protect their top line while transforming themselves from product to patient-centric organizations.
This is the result of a Capgemini Consulting research across Europe and the United States. The aim of the research was to understand the root causes of non-adherence, how the industry has addressed non-adherence in the past and what an innovative approach should look like.
Assessing Opportunities in Patient Adherence
Each year, Capgemini publishes an in-depth analysis of a major life sciences issue. In our 9th edition of Vision & Reality, entitled “Patient Adherence: The Next Frontier in Patient Care," we focus on patient adherence – or rather the lack thereof. There is growing recognition that non-adherence to prescribed treatment is a major public health issue. In the US, it is estimated that additional care for non-adherent patients results in more than $300 billion of unnecessary costs to the healthcare industry each year.
For pharmaceutical companies, improvement in patient adherence represents a significant revenue opportunity that is largely untapped today. In this report, we analyze the current state of patient adherence and the challenges and key success factors involved in improving it.
The time for re-thinking patient adherence is now.
About Vision & Reality
Vision & Reality is a series of annual thought leadership publications exploring key trends and issues that impact the life sciences industry. It combines global primary research with the perspectives of senior executives within major pharmaceutical, biotechnology and medical device companies, together with leading industry experts, payers, physicians and patients. These findings are supplemented with secondary research conducted by Capgemini’s global Strategic Insights Group.
Past Vision & Reality publications include:
- Cost reduction strategies in times of global downturn
- Re-tuning the commercial model in light of increased focus on profitability and changing stakeholder influence
- Value of early commercialization
- Better health outcomes through collaboration
Click here to download the reports or request a copy from .
